{"id":56397,"name":"VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AG","slug":"vifor-fresenius-medical-care-renal-pharma-ag","state":null,"country":"Switzerland","description":"global pharmaceutical company","totalSpending":400000,"filings":12,"yearlySpending":[{"year":2023,"income":120000},{"year":2024,"income":180000},{"year":2025,"income":100000}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"},{"code":"HCR","display":"Health Issues"}],"firms":["CROSSROADS STRATEGIES, LLC"],"lobbyists":["CHERYL JAEGER","JASON VAN PELT","IVELISSE PORROA-GARCIA","MATHEW LAPINSKI","BRITTANY HERNANDEZ","JASON GLEASON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["General education about end stage renal disease (ESRD) and kidney disease policies, including Medicare beneficiary access to pharmaceuticals.","General education about end stage renal disease (ESRD) and kidney disease policies, including Medicare beneficiary access to pharmaceuticals.","General education about end stage renal disease (ESRD) and kidney disease policies, including Medicare beneficiary access to pharmaceuticals.","General education about end stage renal disease (ESRD) and kidney disease policies.","General education about end stage renal disease (ESRD) and kidney disease policies, including Medicare beneficiary access to pharmaceuticals. H.R.5074, Kidney PATIENT Act of 2023."]}